Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
conteltinib (SY-707)
i
Other names:
SY-707, CT 707, CT-707
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Centaurus Biopharma, Shouyao Holdings
Drug class:
Multi-tyrosine kinase inhibitor, ALK inhibitor, IGF-1R inhibitor, FAK inhibitor, Pyk2 inhibitor
Related drugs:
‹
dasatinib (215)
sorafenib (180)
anlotinib (139)
sunitinib (139)
ponatinib (98)
lenvatinib (90)
pazopanib (76)
gilteritinib (75)
cabozantinib tablet (74)
regorafenib (65)
midostaurin (51)
repotrectinib (27)
vandetanib (26)
cabozantinib capsule (24)
nintedanib (18)
TT-00420 (16)
unecritinib (6)
pexidartinib (6)
LY2801653 (6)
SHR 1020 (5)
MGCD516 (5)
AEE788 (4)
APG-2449 (4)
donafenib (2)
AMG 706 (2)
vorolanib (1)
HA121-28 (1)
CT053PTSA (1)
sorafenib nanoparticle (0)
masitinib (0)
TSN084 (0)
DCC-2701 (0)
TAS-115 (0)
SKLB-1028 (0)
crizotinib (312)
entrectinib (178)
alectinib (104)
lorlatinib (94)
ceritinib (67)
brigatinib (50)
ensartinib (42)
iruplinalkib (11)
TAE-684 (9)
SAF-189 (7)
TPX-0131 (4)
envonalkib (3)
TGRX-326 (3)
AZD3463 (2)
OBX02-011 (2)
SY-3505 (1)
NVL-655 (1)
ALK inhibitor (0)
ASP-3026 (0)
CEP-37440 (0)
TY-2136b (0)
dirozalkib (0)
ZG0418 (0)
TSR-011 (0)
BMS-754807 (10)
AMG 479 (10)
ASP7487 (7)
GSK 1838705A (2)
CP-751,871 (1)
BMS-536924 (0)
FPI-1434 (0)
IGV-001 (0)
KW-2450 (0)
LX-101 (0)
NVP-ADW742 (0)
NVP-AEW541 (0)
NVP-TAE226 (0)
teprotumumab-trbw (0)
XL228 (0)
IMC A12 (0)
MK 0646 (0)
MEDI-573 (0)
MM-141 (0)
AXL1717 (0)
SCH 717454 (0)
defactinib (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
IN10018 (3)
GSK2256098 (1)
PF-562271 (1)
FAK-JAK 2 dual Inhib (0)
PF-573228 (0)
dasatinib (215)
sorafenib (180)
anlotinib (139)
sunitinib (139)
ponatinib (98)
lenvatinib (90)
pazopanib (76)
gilteritinib (75)
cabozantinib tablet (74)
regorafenib (65)
midostaurin (51)
repotrectinib (27)
vandetanib (26)
cabozantinib capsule (24)
nintedanib (18)
TT-00420 (16)
unecritinib (6)
pexidartinib (6)
LY2801653 (6)
SHR 1020 (5)
MGCD516 (5)
AEE788 (4)
APG-2449 (4)
donafenib (2)
AMG 706 (2)
vorolanib (1)
HA121-28 (1)
CT053PTSA (1)
sorafenib nanoparticle (0)
masitinib (0)
TSN084 (0)
DCC-2701 (0)
TAS-115 (0)
SKLB-1028 (0)
crizotinib (312)
entrectinib (178)
alectinib (104)
lorlatinib (94)
ceritinib (67)
brigatinib (50)
ensartinib (42)
iruplinalkib (11)
TAE-684 (9)
SAF-189 (7)
TPX-0131 (4)
envonalkib (3)
TGRX-326 (3)
AZD3463 (2)
OBX02-011 (2)
SY-3505 (1)
NVL-655 (1)
ALK inhibitor (0)
ASP-3026 (0)
CEP-37440 (0)
TY-2136b (0)
dirozalkib (0)
ZG0418 (0)
TSR-011 (0)
BMS-754807 (10)
AMG 479 (10)
ASP7487 (7)
GSK 1838705A (2)
CP-751,871 (1)
BMS-536924 (0)
FPI-1434 (0)
IGV-001 (0)
KW-2450 (0)
LX-101 (0)
NVP-ADW742 (0)
NVP-AEW541 (0)
NVP-TAE226 (0)
teprotumumab-trbw (0)
XL228 (0)
IMC A12 (0)
MK 0646 (0)
MEDI-573 (0)
MM-141 (0)
AXL1717 (0)
SCH 717454 (0)
defactinib (8)
LY294002 (7)
AZD0530 (7)
VS-4718 (5)
IN10018 (3)
GSK2256098 (1)
PF-562271 (1)
FAK-JAK 2 dual Inhib (0)
PF-573228 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
ALK positive
Non Small Cell Lung Cancer
ALK positive
Non Small Cell Lung Cancer
SY-707
Sensitive: C2 – Inclusion Criteria
SY-707
Sensitive
:
C2
SY-707
Sensitive: C2 – Inclusion Criteria
SY-707
Sensitive
:
C2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.